UBS Group AG - 30 Sep 2024 SCHEDULE 13G Report for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 per share (AMRX)

Filing Manager: UBS Group AG
Reporting Manager: UBS Group AG
Security: Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 per share
Symbol: AMRX
Shares outstanding: 311,476,536 shares
Disclosed Ownership: 21,491,881 shares
Ownership: 6.9%
Form type: SCHEDULE 13G
Filing time: 30 Oct 2024, 11:04:34 UTC
Date of event: 30 Sep 2024
Next filing: 10 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
UBS Group AG	6.9%	21,491,881	0	14,727	Andrew Johnson	Director